Loading...
Loading...
Browse all stories on DeepNewz
VisitElon Musk's Neuralink Launches Trial for N1 Implant to Control Assistive Robotic Arm
Nov 25, 2024, 06:14 PM
Neuralink, the brain-computer interface (BCI) company founded by Elon Musk, has announced the approval and launch of a new feasibility trial. The trial will test the use of Neuralink's N1 Implant to control an assistive robotic arm. This marks an important first step in the development of brain-computer interfaces, with the potential to restore both digital and physical freedom for individuals with disabilities.
View original story
Markets
No • 50%
Yes • 50%
Trial results published by Neuralink or verified by independent medical journals
No • 50%
Yes • 50%
Official announcements from Neuralink or regulatory bodies such as the FDA
Yes • 50%
No • 50%
Regulatory approval announcements from bodies such as the FDA
0 • 25%
More than 10 • 25%
6-10 • 25%
1-5 • 25%
Trial results published by Neuralink or verified by independent medical journals
Partial success • 25%
Trial discontinued • 25%
Full success • 25%
No success • 25%
Official trial results published by Neuralink or regulatory bodies
Negative • 25%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Results from a major public opinion survey or poll conducted by a reputable organization